Martingale Asset Management L P lifted its stake in shares of Chemed Co. (NYSE:CHE) by 175.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 62,905 shares of the company’s stock after acquiring an additional 40,051 shares during the quarter. Martingale Asset Management L P’s holdings in Chemed were worth $20,136,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Fiduciary Group LLC purchased a new position in Chemed in the first quarter valued at $213,000. Hollencrest Capital Management increased its holdings in Chemed by 5.9% in the first quarter. Hollencrest Capital Management now owns 768 shares of the company’s stock valued at $246,000 after buying an additional 43 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its holdings in Chemed by 79.5% in the first quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 80,795 shares of the company’s stock valued at $25,860,000 after buying an additional 35,795 shares during the last quarter. New York State Common Retirement Fund boosted its stake in Chemed by 20.0% in the first quarter. New York State Common Retirement Fund now owns 39,129 shares of the company’s stock valued at $12,524,000 after acquiring an additional 6,529 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in Chemed by 38.1% in the first quarter. JPMorgan Chase & Co. now owns 57,746 shares of the company’s stock valued at $18,483,000 after acquiring an additional 15,945 shares in the last quarter. 87.15% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director George J. Walsh III sold 646 shares of the stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $326.83, for a total transaction of $211,132.18. Following the completion of the sale, the director now owns 7,070 shares in the company, valued at $2,310,688.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director George J. Walsh III sold 1,000 shares of the stock in a transaction dated Monday, February 25th. The stock was sold at an average price of $328.07, for a total transaction of $328,070.00. Following the sale, the director now owns 7,663 shares of the company’s stock, valued at approximately $2,514,000.41. The disclosure for this sale can be found here. Insiders have sold 21,245 shares of company stock valued at $6,955,533 in the last quarter. Insiders own 3.96% of the company’s stock.

CHE has been the subject of several research analyst reports. Royal Bank of Canada upped their price objective on shares of Chemed from $313.00 to $318.00 and gave the company a “sector perform” rating in a research note on Monday, February 25th. ValuEngine downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. Zacks Investment Research downgraded shares of Chemed from a “hold” rating to a “sell” rating in a research note on Thursday, May 9th. Finally, Oppenheimer upped their price objective on shares of Chemed from $340.00 to $370.00 and gave the company an “outperform” rating in a research note on Tuesday, April 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $347.00.

NYSE CHE opened at $331.66 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.73 and a quick ratio of 0.70. Chemed Co. has a 1 year low of $260.03 and a 1 year high of $341.18. The firm has a market capitalization of $5.42 billion, a price-to-earnings ratio of 27.80, a P/E/G ratio of 3.04 and a beta of 1.18.

Chemed (NYSE:CHE) last released its quarterly earnings data on Monday, April 29th. The company reported $2.92 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.96 by ($0.04). Chemed had a net margin of 11.37% and a return on equity of 35.19%. The company had revenue of $462.03 million during the quarter, compared to analyst estimates of $468.28 million. During the same quarter in the prior year, the company earned $2.72 EPS. The business’s revenue was up 5.2% on a year-over-year basis. On average, sell-side analysts anticipate that Chemed Co. will post 12.65 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 19th. Stockholders of record on Thursday, May 30th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Wednesday, May 29th. This represents a $1.20 annualized dividend and a dividend yield of 0.36%. Chemed’s dividend payout ratio (DPR) is 10.06%.

TRADEMARK VIOLATION WARNING: This report was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://theolympiareport.com/2019/05/24/martingale-asset-management-l-p-buys-40051-shares-of-chemed-co-che.html.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Featured Story: What causes a recession?

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.